SCINOPHARM TAIWAN LTD

Business Nature: Manufacturer (It is a leading active pharmaceutical ingredient (API) manufacturer and developer).

Company Profile:

ScinoPharm Taiwan Ltd. is a premier process research and development as well as active pharmaceutical ingredient (API) manufacturing company. Founded in 1997, the company specializes in providing high-quality APIs for the global pharmaceutical industry. It operates state-of-the-art manufacturing facilities that comply with international regulatory standards, including US FDA, EMA, and PMDA requirements. ScinoPharm offers a comprehensive range of services, including custom synthesis, contract manufacturing, and the development of complex generic APIs, particularly in the fields of oncology and peptides. The company is headquartered in the Southern Taiwan Science Park and is publicly listed on the Taiwan Stock Exchange.

ScinoPharm Taiwan Ltd. manufactures and sells Active Pharmaceutical Ingredients (APIs) and offers contract development and manufacturing services (CDMO). Their product portfolio primarily focuses on complex and high-potency APIs, especially in the oncology therapeutic area.

Key products and services include:

Oncology APIs:

Paclitaxel

Docetaxel

Irinotecan

Gemcitabine

Bortezomib

Cabazitaxel

Eribulin Mesylate

Dacomitinib

Palbociclib

Pomalidomide

Other Therapeutic Area APIs:

Immunosuppressants (for example, Mycophenolate Mofetil)

Cardiovascular APIs

Central Nervous System APIs

Anti-infective APIs

Contract Development and Manufacturing Services (CDMO):

Process Development

Analytical Development

Commercial Manufacturing of APIs

High Potency API (HPAPI) Manufacturing

Regulatory Support and Documentation